Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Science Translational Medicine|January 8, 2016
Early memory phenotypes drive T cell proliferation in patients with pediatric malignanciesNathan Singh, Jessica Perazzelli, Stephan A Grupp, et al.
Cancer Immunology Research|October 18, 2022
Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic SequencingGregory M Chen, Chia-Hui Chen, Jessica Perazzelli, et al.
Journal of Visualized Experiments : Jove|August 22, 2023
Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell ProcessorRene Machietto, Nicholas Giacobbe, Jessica Perazzelli, et al.
Blood|November 9, 2019
A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cellsMarco Ruella, David M Barrett, Olga Shestova, et al.
Molecular and Cellular Biology|August 15, 2018
CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic ReticulumAsen Bagashev, Elena Sotillo, Chih-Hang Anthony Tang, et al.
Human Gene Therapy|July 20, 2018
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell ResponseJessica B Foster, Namrata Choudhari, Jessica Perazzelli, et al.
The Journal of Clinical Investigation|August 30, 2016
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapiesMarco Ruella, David M Barrett, Saad S Kenderian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2022
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19Caroline Diorio, Rawan Shraim, Regina Myers, et al.
Journal for Immunotherapy of Cancer|June 19, 2026
Differential cytokine architecture in patients treated with CART19 versus CART22Caroline Diorio, Rawan Shraim, Anusha Thadi, et al.
Cancer Discovery|October 31, 2015
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 ImmunotherapyElena Sotillo, David M Barrett, Kathryn L Black, et al.
Pageof 2